A State-of-the-Art review published in JACC: Cardiovascular Interventions covers the epidemiology, clinical implications, risk factors and preventive strategies for new-onset conduction disturbances ...

Patients with heart failure (HF) who had an interatrial shunt inserted did not see any significant benefits overall, compared with those who underwent a placebo procedure, after a median 22-month ...

In this interview, Dhanunjaya Lakkireddy, MD, MBA, FACC, and Alison L. Bailey, MD FACC, discuss the Top Electrophysiology (EP) Takeaways from 2024. Dr. Lakkireddy discusses climate change, high school ...

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing ...

Three new performance measures and six new quality measures are included as part of updated "Clinical Performance and Quality Measures for Adults With Heart Failure" released by the ACC and the ...

Update as of August 2024: CMS issued additional instructions for reporting G2211 on Jan. 18 and posted an FAQ document in August 2024 that may be helpful in understanding proper use of G2211.

A continuation strategy of renin-angiotensin system inhibitors (RASIs) before major noncardiac surgery was associated with better post-operative outcomes than discontinuation, based on results from ...

In the ABYSS (Assessment of Beta-Blocker Interruption 1 Year After an Uncomplicated Myocardial Infarction on Safety and Symptomatic Cardiac Events Requiring Hospitalization) trial, interruption of ...

This page features scientific coverage from ACC.19 – including Expert Analyses, Summary Slides and visual abstracts of the hottest late-breaking clinical trials. This post-meeting content is meant to ...

Tell us about you so we can serve you better. ACC requests information from its members on gender, ethnicity and race as part of the College's aim to develop a more diverse and inclusive ...

Heart failure (HF) and atrial fibrillation (AF) are a bad combination, such that AF can exacerbate HF symptoms, worsen left ventricular function, and create multiple adverse consequences despite ...

Our records indicate that the Ovid subscription has been in our system for over a year. Please contact your administrator or librarian to make sure the institutional subscription to Cardiosource Plus ...